# TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects

> **NCT03408470** · PHASE1 · COMPLETED · sponsor: **Theravance Biopharma** · enrollment: 20 (actual)

## Conditions studied

- Intestinal Disorders
- Bowel Diseases, Inflammatory

## Interventions

- **DRUG:** TD-1473 oral capsule
- **DRUG:** [14C]-TD-1473 IV bolus
- **DRUG:** [14C]-TD-1473 Oral Capsule

## Key facts

- **NCT ID:** NCT03408470
- **Lead sponsor:** Theravance Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-31
- **Primary completion:** 2018-02-21
- **Final completion:** 2018-02-21
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03408470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03408470, "TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03408470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*